Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors to Outline New Strategic Plan

Rhea-AI Summary

Nektar Therapeutics (NASDAQ:NKTR) will host a conference call for analysts and investors on April 25, 2022, at 2:00 p.m. PST. The call aims to outline a new strategic plan and provide updates on the company's research and development pipeline. Interested parties can access the live audio-only webcast via the Nektar website, where a replay will also be available until May 27, 2022. For participation, dial (877) 881-2183 (U.S.) or (970) 315-0453 (international) with Conference ID: 5888057.

SAN FRANCISCO, April 22, 2022 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) will host an analyst and investor conference call with Nektar executives on Monday, April 25, 2022, at 2:00 p.m. Pacific Standard Time (PST), to outline a new strategic plan for the company and provide updates for the company's research and development pipeline.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through May 27, 2022.

To access the conference call, follow these instructions:

Dial: (877) 881-2183 (U.S); (970) 315-0453 (international)
Conference ID: 5888057 (Nektar Therapeutics is the host)

About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company developing investigational medicines in oncology, immunology, and inflammatory diseases. The company also has a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-therapeutics-to-host-webcast-conference-call-for-analysts--investors-to-outline-new-strategic-plan-301530770.html

SOURCE Nektar Therapeutics

FAQ

What is the date and time of Nektar Therapeutics' conference call?

Nektar Therapeutics' conference call is scheduled for April 25, 2022, at 2:00 p.m. PST.

How can I access the webcast of the Nektar Therapeutics conference call?

You can access the live audio-only webcast of the conference call through the Nektar website's Home Page and Investors section.

What is the purpose of the Nektar Therapeutics conference call?

The conference call is intended to outline a new strategic plan and provide updates on Nektar's research and development pipeline.

When will the replay of the Nektar Therapeutics conference call be available?

The replay of the conference call will be available until May 27, 2022.

What is the dial-in information for the Nektar Therapeutics conference call?

To join the call, dial (877) 881-2183 for U.S. or (970) 315-0453 for international participants, using Conference ID: 5888057.